ERG and cancer: Data from next generation sequencing studies demonstrate that such deletions are more prevalent than mutations of coding genes and many of these deletions have been linked to either ERG positive (i.e. PTEN and 3p13) or ERG negative cancers (i.e. 6q15 and 5q23) [48–52].